Scopolamine Patch, Extended Release
Product Images NDC 71335-3014

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 71335-3014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713353014)

This is a package insert for a transdermal system containing 1.3 mg scopolamine to be delivered over 3 days. The inactive components include crospovidone, isopropyl palmitate, and polyethylene. It is advised to keep the medication out of reach of children and store it upright at room temperature. Caution is recommended due to possible side effects like drowsiness and blurred vision. The package insert also mentions the need to remove the transdermal system before undergoing an MRI scan to avoid burns.*

FDA Label Image

Extended Label Label (Lbl713353014extendedlabel)

This is a set of instructions for the dosage and administration of a transdermal system medication. It advises washing and drying hands before application, using only one system at a time, not cutting the system, discarding the plastic backing, applying to a hairless area behind one ear, and washing hands after application.*

FDA Label Image

Chemical Structure (Scopolamine 01)

FDA Label Image

Image (Scopolamine 02)

This text provides a brief description of the layers of a transdermal drug delivery system. It mentions the backing membrane, drug layer, rate-controlling membrane, and contact layer. The "TReeaseLiner" appears to refer to the release liner. This information is useful for understanding the structure and function of transdermal patches.*

FDA Label Image

Figure 1 (Scopolamine 03)

This text seems to be describing a disposable release liner with metallic adhesive surface and tan backing membrane. It includes an imprint "Scopolamine 1mg/3 days". It is shown in Figure 1.*

FDA Label Image

Figure 2 (Scopolamine 04)

FDA Label Image

Figure 3 (Scopolamine 05)

FDA Label Image

Figure 4 (Scopolamine 06)

This is a tan-colored transdermal system with a metallic adhesive surface and a clear, disposable release liner. The product is imprinted and the design is shown in Figure 4.*

FDA Label Image

Figure 5 (Scopolamine 07)

This is a description of a tan-colored transdermal system that is imprinted. The image shows a visual representation labeled as Figure 5.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.